Evidence map›Paper›PMID 40597844›Full record

ArticleBMC infectious diseases2025

Respiratory bacterial and viral pathogen spectrum among influenza-positive and influenza-negative patients.

Jing Shi, Shi Han, Yating Zhang, Xiaohua Lu, Yunxia Gan, Narenqimuge Tong, Lu Ma, Hang Zhuan, Ying Dai, Yaqi Ji and 3 more

Abstract read
In one paragraph

Article in BMC infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Jing Shi *Xiangyang Center for Disease Control and Prevention, Xiangyang, Hubei, 44102, China.
Shi Han *Wuhan University of Science and Technology, Wuhan, Hubei, 430081, China.
Yating Zhang *Institute of Health Inspection and Testing, Hubei Provincial Center for Disease Control and Prevention, Wuhan, Hubei, 430079, China.
Xiaohua LuWuhan Institute of Biological Products Co. Ltd, Wuhan, Hubei, 430207, China.
Yunxia GanXiangyang Center for Disease Control and Prevention, Xiangyang, Hubei, 44102, China.
Narenqimuge TongXiangyang Center for Disease Control and Prevention, Xiangyang, Hubei, 44102, China.
Lu MaXiangyang Center for Disease Control and Prevention, Xiangyang, Hubei, 44102, China.
Hang ZhuanInstitute of Health Inspection and Testing, Hubei Provincial Center for Disease Control and Prevention, Wuhan, Hubei, 430079, China.
Ying DaiInstitute of Health Inspection and Testing, Hubei Provincial Center for Disease Control and Prevention, Wuhan, Hubei, 430079, China.
Yaqi JiWuhan Institute of Biological Products Co. Ltd, Wuhan, Hubei, 430207, China.
Guoming LiInstitute of Health Inspection and Testing, Hubei Provincial Center for Disease Control and Prevention, Wuhan, Hubei, 430079, China. liguominghb@163.com.
Dan ChenWuhan University of Science and Technology, Wuhan, Hubei, 430081, China. chendan@wust.edu.cn.
Lu YangWuhan Institute of Biological Products Co. Ltd, Wuhan, Hubei, 430207, China. yanglulu2010@163.com.

Funding

Hubei Province Technological Innovation Program Project 2024BCB023Hubei province Xiangyang city medical and health field science and technology project 2021YL42
6 · The paper itself

Abstract

backgroundRespiratory tract infections are a significant burden on public health worldwide, with influenza being a prominent viral infection. Although influenza is known to predispose individuals to secondary bacterial infections, the precise spectrum of respiratory pathogens in influenza-positive and negative-patients remains unclear. This study aims to gain insights into the pathogenesis, epidemiology, and clinical implications of co-infections, facilitating the development of preventive and targeted interventions.

methodsA total of 1,596 oropharyngeal swabs from influenza-like cases were collected from 2021 to 2023 and analyzed using real-time PCR. These samples tested for 9 different respiratory bacteria, such as Streptococcus pneumonia and Neisseria meningitides, and 8 respiratory viruses, including human influenza virus and human metapneumovirus.

resultsThis study collected samples from 403 influenza-positive patients and 1,193 influenza-negative patients, among which bacterial and viral pathogens were detected. The gender distribution among the influenza-positive and influenza-negative patients was approximately equal with males slightly outnumbering females. The age range of the participants varied from one month to 97 years old. Co-infection of influenza virus with other common respiratory bacterial and viral pathogens was identified and evaluated highly relevant for an accurate understanding of the disease's overall burden. Specifically, Streptococcus pneumoniae and Haemophilus influenzae were significantly more prevalent in influenza-positive patients (30.77% and 33.00%, respectively) compared to influenza-negative patients (22.21% and 22.46%, respectively). Conversely, Human parainfluenza viruses and Human rhinoviruses were more prevalent in influenza-negative patients (4.27% and 5.62%, respectively) compared to influenza-positive patients (0.74% and 1.49%, respectively). A total of 995 cases (62.34%) tested positive for nucleic acid, with 254 cases of single-virus infections, 297 cases of single-bacterial infections, and 444 cases of mixed infections. The most common co-infection pattern was H. influenzae and influenza virus, accounting for 133 cases (29.95% of mixed infections).

conclusionOur study highlights the high prevalence of co-infections in respiratory infections, with significant differences in pathogen distribution between influenza-positive and influenza-negative patients. Influenza-positive patients had higher rates of S. pneumoniae and H. influenzae infections, while influenza-negative patients had higher rates of Human parainfluenza viruses and Human rhinoviruses. These findings underscore the importance of comprehensive pathogen testing for accurate diagnosis and tailored treatment strategies.

trial registrationThe samples for this study were obtained from the influenza surveillance network of Hubei Province. The information contained in the study does not pose any ethical or privacy risks to the sample providers. The need for ethics approval for this study was waived by the statement from the research ethics board of the Hubei Provincial Center for Disease Control and Prevention. Additionally, the requirement of obtaining informed consent to participate was also waived.

Indexed as

BacteriaCoinfectionInfluenza, HumanRespiratory Tract InfectionsAdolescentAdultAgedAged, 80 and overChildChild, PreschoolFemaleHumansInfantMaleMiddle AgedOrthomyxoviridaeInfluenzaInfluenza-like illnessRespiratory bacterial pathogenRespiratory viral pathogenStreptococcus pneumoniae

Identifiers

PMID40597844
PMCPMC12219130

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.